These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 24197987

  • 21. Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research.
    Avery RA, Ferner RE, Listernick R, Fisher MJ, Gutmann DH, Liu GT.
    J Neurooncol; 2012 Oct; 110(1):1-7. PubMed ID: 22843451
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.
    Ullrich NJ, Prabhu SP, Packer RJ, Goldman S, Robison NJ, Allen JC, Viskochil DH, Gutmann DH, Perentesis JP, Korf BR, Fisher MJ, Kieran MW, NF Clinical Trials Consortium.
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28833. PubMed ID: 33336845
    [Abstract] [Full Text] [Related]

  • 25. Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab.
    Avery RA, Hwang EI, Jakacki RI, Packer RJ.
    JAMA Ophthalmol; 2014 Jan; 132(1):111-4. PubMed ID: 24232489
    [Abstract] [Full Text] [Related]

  • 26. Visual loss in orbitofacial neurofibromatosis type 1.
    Oystreck DT, Morales J, Chaudhry I, Alorainy IA, Elkhamary SM, Pasha TM, Bosley TM.
    Ophthalmology; 2012 Oct; 119(10):2168-73. PubMed ID: 22709421
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Optic Pathway Gliomas in Neurofibromatosis Type 1.
    Campen CJ, Gutmann DH.
    J Child Neurol; 2018 Jan; 33(1):73-81. PubMed ID: 29246098
    [Abstract] [Full Text] [Related]

  • 29. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
    Falzon K, Drimtzias E, Picton S, Simmons I.
    Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
    [Abstract] [Full Text] [Related]

  • 30. Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.
    Avery RA, Mansoor A, Idrees R, Trimboli-Heidler C, Ishikawa H, Packer RJ, Linguraru MG.
    Neurology; 2016 Dec 06; 87(23):2403-2407. PubMed ID: 27815398
    [Abstract] [Full Text] [Related]

  • 31. Vision-related quality-of-life in pediatric primary brain tumor patients.
    Peragallo JH, Bruce BB, Vasseneix C, Jariyakosol S, Janss AJ, Newman NJ, Biousse V.
    J Neurooncol; 2021 Sep 06; 154(3):365-373. PubMed ID: 34462885
    [Abstract] [Full Text] [Related]

  • 32. Pretreatment Endocrine Disorders Due to Optic Pathway Gliomas in Pediatric Neurofibromatosis Type 1: Multicenter Study.
    Santoro C, Perrotta S, Picariello S, Scilipoti M, Cirillo M, Quaglietta L, Cinalli G, Cioffi D, Di Iorgi N, Maghnie M, Gallizia A, Parpagnoli M, Messa F, De Sanctis L, Vannelli S, Marzuillo P, Miraglia Del Giudice E, Grandone A.
    J Clin Endocrinol Metab; 2020 Jun 01; 105(6):. PubMed ID: 32294191
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
    Kuenzle C, Weissert M, Roulet E, Bode H, Schefer S, Huisman T, Landau K, Boltshauser E.
    Neuropediatrics; 1994 Dec 01; 25(6):295-300. PubMed ID: 7770126
    [Abstract] [Full Text] [Related]

  • 36. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening.
    Levin MH, Armstrong GT, Broad JH, Zimmerman R, Bilaniuk LT, Feygin T, Li Y, Liu GT, Fisher MJ.
    Br J Ophthalmol; 2016 Apr 01; 100(4):510-4. PubMed ID: 26294105
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1.
    Dotto PF, Berezovsky A, Cappellano AM, da Silva NS, Sacai PY, Silva FAB, Fernandes AG, Rocha DM, Salomão SR.
    Doc Ophthalmol; 2018 Jun 01; 136(3):177-189. PubMed ID: 29766345
    [Abstract] [Full Text] [Related]

  • 39. Correlations Between Subjective Evaluation of Quality of Life, Visual Field Loss, and Performance in Simulated Activities of Daily Living in Glaucoma Patients.
    Azoulay-Sebban L, Zhao Z, Zenouda A, Lombardi M, Gutman E, Brasnu E, Hamard P, Sahel JA, Baudouin C, Labbé A.
    J Glaucoma; 2020 Oct 01; 29(10):970-974. PubMed ID: 32649451
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.